4 Firms Steer French COVID-19 Vaccine Maker's $94M US IPO
A French maker of traveler vaccines with a COVID-19 candidate in the pipeline went public to receptive U.S. investors Thursday after completing a $93.5 million initial public offering, guided by four...To view the full article, register now.
Already a subscriber? Click here to view full article